Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether mitoxantrone and prednisone are more
effective with or without prinomastat in treating patients with metastatic prostate cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of mitoxantrone and
prednisone with or without prinomastat in treating patients who have metastatic prostate
cancer that has not responded to hormone therapy.